Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-26 Sale | 2026-06-29 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 11,421 | $26.08 | $297,912 | 13,088 (Direct) | View |
| 2026-05-26 Sale | 2026-05-27 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 5,401 | $21.18 | $114,393 | 24,509 (Direct) | View |
| 2026-05-04 Sale | 2026-05-05 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 1,332 | $21.79 | $29,024 | 31,725 (Direct) | View |
| 2026-05-04 Sale | 2026-05-05 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 3,506 | $21.79 | $76,396 | 72,960 (Direct) | View |
| 2026-04-07 Sale | 2026-04-07 7:57 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2,709 | $22.2 | $60,140 | 62,836 (Direct) | View |
| 2026-04-07 Sale | 2026-04-07 7:55 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 1,030 | $22.2 | $22,866 | 27,865 (Direct) | View |
| 2026-03-25 Sale | 2026-03-26 8:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Owen Adams Catherine Chief Executive Officer | 11,641 | $21.47 | $249,932 | 85,333 (Direct) | View |
| 2026-03-25 Sale | 2026-03-26 8:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 3,435 | $21.47 | $73,749 | 23,426 (Direct) | View |
| 2026-03-25 Sale | 2026-03-26 8:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 3,844 | $21.47 | $82,531 | 33,827 (Direct) | View |
| 2026-03-25 Sale | 2026-03-26 8:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 1,942 | $21.57 | $41,895 | 36,052 (Direct) | View |
| 2026-03-25 Sale | 2026-03-26 8:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 7,385 | $21.55 | $159,136 | 97,041 (Direct) | View |
| 2026-02-09 Sale | 2026-02-10 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 6,950 | $23.38 | $162,491 | 20,554 (Direct) | View |
| 2025-11-18 Sale | 2025-11-19 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 10,262 | $23.69 | $243,114 | 53,338 (Direct) | View |
| 2025-11-18 Sale | 2025-11-19 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 4,084 | $23.69 | $96,754 | 25,058 (Direct) | View |
| 2025-11-10 Sale | 2025-11-12 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director | 30,000 | $22.37 | $670,983 | 4,041 (Direct) | View |
| 2025-09-15 Sale | 2025-09-16 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 3,498 | $23.65 | $82,728 | 43,447 (Direct) | View |
| 2025-09-02 Sale | 2025-09-03 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 1,600 | $25.98 | $41,560 | 25,382 (Direct) | View |
| 2025-08-18 Sale | 2025-08-19 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 22,000 | $25.18 | $554,024 | 40,130 (Direct) | View |
| 2025-06-04 Sale | 2025-06-05 6:01 pm | ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director | 14,446 | $21.78 | $314,634 | 15,095 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-29 Option Award | 2026-06-02 4:32 pm | N/A 2036-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 82,638 | $0 | 39,654,355 (Indirect) | View |
| 2026-05-29 Option Award | 2026-06-01 6:00 pm | N/A 2036-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director | 25,315 | $0 | 68,463 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-01 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director | 8,107 | $0 | 68,463 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-01 6:00 pm | N/A 2036-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director | 25,315 | $0 | 58,223 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-01 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director | 8,107 | $0 | 58,223 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-01 6:00 pm | N/A 2036-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director | 25,315 | $0 | 48,517 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-01 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director | 8,107 | $0 | 48,517 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-01 6:00 pm | N/A 2036-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | Poole Jonathan Director | 25,315 | $0 | 27,325 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-01 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Poole Jonathan Director | 2,010 | $0 | 27,325 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-01 6:00 pm | N/A 2036-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 25,315 | $0 | 58,804 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-01 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 8,107 | $0 | 58,804 (Direct) | View |
| 2026-05-29 Option Award | 2026-06-01 6:00 pm | N/A 2036-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director | 25,315 | $0 | 37,463 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-01 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director | 8,107 | $0 | 37,463 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-05 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 2,596 | $0 | 31,725 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-05 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 6,815 | $0 | 72,960 (Direct) | View |
| 2026-04-05 Exercise | 2026-04-07 7:57 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 5,276 | $0 | 62,836 (Direct) | View |
| 2026-04-05 Exercise | 2026-04-07 7:55 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 2,010 | $0 | 27,865 (Direct) | View |
| 2026-03-24 Exercise | 2026-03-26 8:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Owen Adams Catherine Chief Executive Officer | 23,509 | $0 | 85,333 (Direct) | View |
| 2026-03-24 Exercise | 2026-03-26 8:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 6,715 | $0 | 23,426 (Direct) | View |
| 2026-03-24 Exercise | 2026-03-26 8:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 7,515 | $0 | 33,827 (Direct) | View |
| 2026-03-24 Exercise | 2026-03-26 8:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 3,769 | $0 | 36,052 (Direct) | View |
| 2026-03-24 Exercise | 2026-03-26 8:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 14,316 | $0 | 97,041 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-20 6:01 pm | N/A 2036-03-02 | ACADIA PHARMACEUTICALS INC | ACAD | Poole Jonathan Director | 17,275 | $0 | 17,275 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 6:00 pm | N/A 2036-03-05 | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 28,098 | $0 | 28,098 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 6:00 pm | N/A 2036-03-05 | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 117,073 | $0 | 117,073 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 6:00 pm | N/A 2036-03-05 | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 117,073 | $0 | 117,073 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 6:00 pm | N/A 2036-03-05 | ACADIA PHARMACEUTICALS INC | ACAD | Garner Thomas EVP, Chief Commercial Officer | 126,440 | $0 | 126,440 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 6:00 pm | N/A 2036-03-05 | ACADIA PHARMACEUTICALS INC | ACAD | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 131,122 | $0 | 131,122 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 6:00 pm | N/A 2036-03-05 | ACADIA PHARMACEUTICALS INC | ACAD | Owen Adams Catherine Chief Executive Officer | 339,514 | $0 | 339,514 (Direct) | View |
| 2026-02-06 Exercise | 2026-02-10 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 12,944 | $0 | 20,554 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 19,826 | $0 | 53,338 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 7,932 | $0 | 25,058 (Direct) | View |
| 2025-09-12 Option Award | 2025-09-16 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 6,815 | $0 | 43,447 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 6:05 pm | N/A 2035-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | SOLAND DANIEL B Director | 21,900 | $0 | 65,941 (Direct) | View |
| 2025-05-29 Exercise | 2025-06-02 6:05 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | SOLAND DANIEL B Director | 9,387 | $0 | 65,941 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 6:05 pm | N/A 2035-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director | 21,900 | $0 | 46,701 (Direct) | View |
| 2025-05-29 Exercise | 2025-06-02 6:05 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director | 9,387 | $0 | 46,701 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 6:05 pm | N/A 2035-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director | 21,900 | $0 | 56,941 (Direct) | View |
| 2025-05-29 Exercise | 2025-06-02 6:05 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director | 9,387 | $0 | 56,941 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 6:05 pm | N/A 2035-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 21,900 | $0 | 48,882 (Direct) | View |
| 2025-05-29 Exercise | 2025-06-02 6:05 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 9,387 | $0 | 48,882 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 6:05 pm | N/A 2035-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director | 21,900 | $0 | 55,941 (Direct) | View |
| 2025-05-29 Exercise | 2025-06-02 6:05 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director | 9,387 | $0 | 55,941 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 6:05 pm | N/A 2035-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director | 21,900 | $0 | 51,441 (Direct) | View |
| 2025-05-29 Exercise | 2025-06-02 6:05 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director | 9,387 | $0 | 51,441 (Direct) | View |